Related Experiment Video
Updated: Jul 22, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Challenges in systematic reviews that evaluate drug efficacy or effectiveness
P Lina Santaguida1, Mark Helfand, Parminder Raina
1McMaster University Evidence-based Practice Centre, Hamilton, Ontario, Canada.
Annals of Internal Medicine
|June 22, 2005
Summary
Systematic reviews guide treatment choices by evaluating drug effectiveness and identifying evidence gaps. Improving these reviews ensures better clinical decision-making and policy setting for various patient subgroups.
Area of Science:
- Pharmacology and Clinical Therapeutics
- Evidence-Based Medicine
- Health Policy Research
Background:
- Systematic reviews are increasingly vital for decision-making in healthcare, influencing treatment selection and policy development.
- Current systematic reviews may not always provide comprehensive information for clinical practice, necessitating improvements in their methodology and scope.
- Consumers, clinicians, regulatory bodies, and insurers rely on these reviews for evidence-based treatment choices.
Purpose of the Study:
- To enhance the relevance and validity of systematic reviews for drug interventions.
- To guide reviewers in formulating clinically meaningful questions and identifying appropriate study designs.
- To improve the applicability of systematic review findings to real-world clinical practice.
Main Methods:
- Formulating review questions aligned with specific clinical therapeutic aims.
- Identifying and including diverse study types beyond direct comparator trials, including unpublished data.
- Delineating clinically important patient subgroups and relevant therapeutic outcomes.
- Assessing the applicability of included studies to actual clinical practice settings.
Main Results:
- Systematic reviews can effectively distinguish evidence-based claims of drug effectiveness.
- Reviews can identify critical information gaps and limitations in the evidence base.
- Findings can address differential drug effectiveness across specific patient subgroups.
- Improved review methods enhance the utility of evidence for clinical decision-making.
Conclusions:
- Enhanced systematic review methodologies are crucial for improving the quality and applicability of evidence for drug therapies.
- Reviewers must consider specific clinical contexts, patient subgroups, and diverse data sources to maximize review utility.
- More rigorous and comprehensive systematic reviews will better support informed clinical practice and health policy.
More Related Videos
04:34Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
08:36The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
Published on: April 19, 2024
Related Concept Videos
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:22Dose-Response Relationship: Potency and Efficacy
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:20Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...